Cell-mediated tumor immunity measured in vitro and in vivo with soluble tumor-specific antigens
Meltzer, M.S.; Oppenheim, J.J.; Littman, B.H.; Leonard, E.J.; Rapp, H.J.
Journal of the National Cancer Institute 49(3): 727-734
1972
ISSN/ISBN: 0027-8874
PMID: 4345967
Accession: 042476319
PDF emailed within 1 workday: $29.90
Related References
Rao, V.S.; Bonavida, B. 1976: Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens Cancer Research 36(4): 1384-1391Brannen, G.E.; Adams, J.S.; Santos, G.W. 1974: In vivo demonstration of tumor specific immunity with soluble tumor antigens in the mouse Proceedings of the American Association for Cancer Research 15: 76
Ting, C.C.; Rodrigues, D.; Nordan, R. 1982: Studies of the mechanisms for the induction of in vivo tumor immunity. VI. Induction of specific and nonspecific cell-mediated immunity in tumor-bearing hosts and its correlation with transplantation tumor immunity Cellular Immunology 66(1): 45-58
Burton, R.C.; Warner, N.L. 1977: Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses Journal of the National Cancer Institute 58(3): 701-709
Brannen, G.E.; Adams, J.S.; Santos, G.W. 1974: Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. in vivo demonstration of immunity with three preparations of soluble antigens Journal of the National Cancer Institute 53(1): 165-175
Bosslet, K.; Schirrmacher, V.; Shantz, G. 1979: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro International Journal of Cancer 24(3): 303-313
Carbone, G.; Colombo, M.P.; Sensi, M.L.; Cernuschi, A.; Parmiani, G. 1983: In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas International Journal of Cancer 31(4): 483-489
Fujiwara, H.; Hamaoka, T.; Shearer, G.M.; Yamamoto, H.; Terry, W.D. 1980: The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes Journal of Immunology 124(2): 863-869
Rodrigues, D.; Ting, C.C. 1981: Studies of the mechanisms for the induction of in vivo tumor immunity. V. a comparison of the generation of the primary cell-mediated cytotoxic response using in vitro mixed-lymphocyte--tumor cell culture and an in vivo technique Cellular Immunology 59(1): 127-137
Sano, S.; Izumi, Y.; Sugihara, S.; Nakajima, H.; Fujiwara, H.; Hamaoka, T. 1987: The generation of tumor-specific in vivo protective immunity in the tumor mass from mice rendered tolerant to tumor antigens Cancer Immunology Immunotherapy: Cii 25(2): 105-110
Schirrmacher, V.; Shantz, G.; Clauer, K.; Komitowski, D.; Zimmermann, H.P.; Lohmann-Matthes, M.L. 1979: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo International Journal of Cancer 23(2): 233-244
Pellis, N.R.; Shulan, D.J.; Kahan, B.D. 1976: Specific tumor immunity induced with soluble materials: purification of antigens inducing tumor resistance Biochemical and Biophysical Research Communications 71(4): 1251-1258
Chauvenet, P.H.; Smith, R.T. 1978: Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength International Journal of Cancer 22(1): 79-90
Burton, R.C.; Chism, S.E.; Warner, N.L. 1977: In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens Journal of Immunology 118(3): 971-980
Chism, S.E.; Burton, R.C.; Warner, N.L. 1977: In vitro induction of tumor specific immunity assessment of specificity of response to tumor antigens Proceedings of the American Association for Cancer Research 18: 26
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III: enhanced generation of tumor-specific Lyt-1+2-T cells is reponsible for augmented tumor immunity in vivo Cancer Immunology and ImmunoTherapy 21(3): 193-198
Yoshioka, T.; Fukuzawa, M.; Takai, Y.; Wakamiya, N.; Ueda, S.; Kato, S.; Fujiwara, H.; Hamaoka, T. 1986: The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo Cancer Immunology Immunotherapy: Cii 21(3): 193-198
Hostetler, L.W.; Romerdahl, C.A.; Kripke, M.L. 1989: Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo Cancer Research 49(5): 1207-1213
Schroit, A.J.; Key, M.E. 1983: Induction of syngeneic tumour-specific immunity by liposomes reconstituted with L2C tumour-cell antigens Immunology 49(3): 431-438
Hanna, M.G.Jr; Bucana, C. 1975: Possible mechanisms of bcg immuno therapy tumor specific immunity and cross reacting antigens of bcg and tumor cell surface Crispen, Ray G (Ed ) Neoplasm Immunity: Theory And Application Proceedings Of A Chicago Symposium Chicago, Ill , U S A , Sept 11, 1974 Vii+204p Illus Itr Biomedical Research, University Of Illinois: Chicago, Ill , U S A ISBN 0-915314-02-9: 65-85